Luigi Costa
Voorzitter bij PinCell Srl
Profiel
Luigi Costa is the founder of Noema Pharma AG.
He currently serves as the Chairman of PinCell Srl.
Previously, he served as the Chief Executive Officer of Nordic Nanovector ASA from 2014 to 2018.
He also held managing director positions at Amgen Dompé SpA and Amgen SAS, and was the Head-International Oncology Franchise at Amgen, Inc. Additionally, he served as the Vice President-Europe, Middle East & Africa Region at Onyx Pharmaceuticals, Inc. Mr. Costa received his undergraduate degree from the University of Parma and his MBA from SDA Bocconi School of Management.
Actieve functies van Luigi Costa
Bedrijven | Functie | Begin |
---|---|---|
PinCell Srl
PinCell Srl BiotechnologyHealth Technology PinCell Srl is a holding company, which engages in the development of anti-inflammatory therapy for the treatment of orphan diseases of the skin. Its clinical work and research focuses on drug discovery, drug physicochemical characterization, preclinical pharmacology and toxicology studies, and early phase clinical trials on healthy volunteers. The company was founded by Carlo Pincelli and Alessandra Marconi in October 2008 and is headquartered in Milan, Italy. | Voorzitter | 07-05-2020 |
Eerdere bekende functies van Luigi Costa
Bedrijven | Functie | Einde |
---|---|---|
Noema Pharma AG
Noema Pharma AG BiotechnologyHealth Technology Noema Pharma AG is a biotechnology company, which engages in the development of orphan neurological disorder therapies. It focuses on understanding and meeting patient needs using novel therapies. The company was founded by Luigi Costa and George Garibaldi and is headquartered in Basel, Switzerland. | Algemeen Directeur | 21-06-2023 |
THOR MEDICAL | Algemeen Directeur | 20-04-2018 |
ONCOPEPTIDES AB | Directeur/Bestuurslid | - |
Amgen SAS
Amgen SAS Medical DistributorsDistribution Services Amgen SAS manufactures and distributes medicines. It specializes in biopharmaceutical products for diseases in the fields of oncology, cardiology, rheumatology, and nephrology. The company was founded in 1990 and is headquartered in Boulogne-Billancourt, France. | Algemeen Directeur | - |
Amgen Dompé SpA
Amgen Dompé SpA Miscellaneous Commercial ServicesCommercial Services Amgen Dompé SpA wholesales pharmaceutical products. The company is headquartered in Milan, Italy. | Algemeen Directeur | - |
Opleiding van Luigi Costa
University of Parma | Undergraduate Degree |
SDA Bocconi School of Management | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
AMGEN INC. | Health Technology |
ONCOPEPTIDES AB | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Amgen Dompé SpA
Amgen Dompé SpA Miscellaneous Commercial ServicesCommercial Services Amgen Dompé SpA wholesales pharmaceutical products. The company is headquartered in Milan, Italy. | Commercial Services |
Amgen SAS
Amgen SAS Medical DistributorsDistribution Services Amgen SAS manufactures and distributes medicines. It specializes in biopharmaceutical products for diseases in the fields of oncology, cardiology, rheumatology, and nephrology. The company was founded in 1990 and is headquartered in Boulogne-Billancourt, France. | Distribution Services |
Nordic Nanovector ASA
Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
PinCell Srl
PinCell Srl BiotechnologyHealth Technology PinCell Srl is a holding company, which engages in the development of anti-inflammatory therapy for the treatment of orphan diseases of the skin. Its clinical work and research focuses on drug discovery, drug physicochemical characterization, preclinical pharmacology and toxicology studies, and early phase clinical trials on healthy volunteers. The company was founded by Carlo Pincelli and Alessandra Marconi in October 2008 and is headquartered in Milan, Italy. | Health Technology |
Noema Pharma AG
Noema Pharma AG BiotechnologyHealth Technology Noema Pharma AG is a biotechnology company, which engages in the development of orphan neurological disorder therapies. It focuses on understanding and meeting patient needs using novel therapies. The company was founded by Luigi Costa and George Garibaldi and is headquartered in Basel, Switzerland. | Health Technology |